Pinealon Dosage Calculator
Pinealon is a synthetic tripeptide bioregulator composed of L-glutamic acid, L-aspartic acid, and L-arginine (Glu-Asp-Arg, or EDR).
50mcg · Daily
Summary: Add 2mL BAC water to your 20mg vial. Draw to 0.5 units on a U-100 syringe for a 50mcg dose. This vial will last 400 doses.
Cycle Planner
Pinealon Pharmacokinetics
Pharmacokinetics — Active Dose Over Time
t½ = ~15-30 minutes (estimated)Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
Pinealon Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 50mcg | Daily |
| Moderate | 100mcg | Daily |
| Aggressive | 200mcg | Daily |
Note: Tripeptide bioregulator (Glu-Asp-Arg). Targets pineal gland and CNS. Dose in the evening. Oral capsules also available. Very limited human PK data — dosing based on Russian bioregulator protocols.
About Pinealon
Pinealon is a synthetic tripeptide bioregulator composed of L-glutamic acid, L-aspartic acid, and L-arginine (Glu-Asp-Arg, or EDR). Developed by Prof. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, it belongs to the cytomedins — short peptides derived from tissue-specific extracts. Pinealon is proposed to target the pineal gland and central nervous system, with preclinical studies suggesting it may cross the blood-brain barrier and interact directly with chromatin to influence gene expression. Animal and in vitro research has linked EDR to increased neuronal viability, reduced apoptosis, and modulation of BDNF and antioxidant pathways. However, the evidence base is narrow: most studies originate from a single research group, many are published only in Russian, and no controlled human clinical trials have been completed. Claims around sleep quality, circadian rhythm correction, and cognitive enhancement remain preliminary. Users should treat Pinealon as an experimental compound with significant evidence gaps.